WELLS FARGO & COMPANY/MN - DECIPHERA PHARMACEUTICALS IN ownership

DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 81 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of DECIPHERA PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$477,267
-43.1%
37,521
-37.0%
0.00%
Q2 2023$839,210
+12.2%
59,603
+23.2%
0.00%
Q1 2023$747,626
+2392.1%
48,390
+2898.1%
0.00%
Q3 2022$30,000
-3.2%
1,614
-32.1%
0.00%
Q2 2022$31,000
-82.2%
2,377
-87.4%
0.00%
Q1 2022$174,000
-41.2%
18,821
-37.9%
0.00%
Q4 2021$296,000
-87.4%
30,307
-56.1%
0.00%
-100.0%
Q3 2021$2,345,000
-70.4%
69,022
-68.1%
0.00%
-50.0%
Q2 2021$7,912,000
-67.9%
216,114
-60.6%
0.00%
-66.7%
Q1 2021$24,617,000
-38.6%
548,990
-21.8%
0.01%
-40.0%
Q4 2020$40,085,000
+51.1%
702,387
+35.8%
0.01%
+42.9%
Q3 2020$26,537,000
-10.8%
517,294
+3.8%
0.01%
-22.2%
Q2 2020$29,754,000
+55.3%
498,236
+7.0%
0.01%
+28.6%
Q1 2020$19,162,000
-36.2%
465,426
-3.6%
0.01%
-12.5%
Q4 2019$30,038,000
+97.5%
482,608
+7.7%
0.01%
+100.0%
Q3 2019$15,210,000
+936.1%
448,127
+588.1%
0.00%
Q2 2019$1,468,000
+312.4%
65,123
+325.2%
0.00%
Q1 2019$356,000
+10.6%
15,317
-0.1%
0.00%
Q4 2018$322,000
-33.2%
15,329
+23.2%
0.00%
Q3 2018$482,000
+181.9%
12,440
+187.1%
0.00%
Q2 2018$171,000
+81.9%
4,333
-7.8%
0.00%
Q1 2018$94,000
+235.7%
4,700
+286.2%
0.00%
Q4 2017$28,0000.0%1,217
-18.9%
0.00%
Q3 2017$28,0001,5000.00%
Other shareholders
DECIPHERA PHARMACEUTICALS IN shareholders Q1 2019
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 1,209,571$69,030,00015.95%
SV Health Investors, LLC 449,951$25,679,00012.37%
Sunesis Advisors, LLC 96,299$5,496,0004.45%
Redmile Group, LLC 4,437,968$253,275,0003.07%
Consonance Capital Management LP 484,671$27,660,0002.58%
SECTORAL ASSET MANAGEMENT INC 488,842$27,898,0001.97%
Opaleye Management Inc. 222,000$12,670,0001.66%
Eversept Partners, LP 246,240$14,052,9171.65%
SILVERARC CAPITAL MANAGEMENT, LLC 38,620$2,204,0001.28%
Avoro Capital Advisors LLC 1,300,000$74,191,0001.28%
View complete list of DECIPHERA PHARMACEUTICALS IN shareholders